Search research articles
Contact Us
Filters
Showing results (161-170 of 210) with videos related to
Page
of 21
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 13, 2012
Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy
A Awada, L Dirix, L Manso Sanchez, et al.
Saudi Medical Journal
|
September 5, 2001
Complications of carbon monoxide poisoning
M S Al-Moamary, A S Al-Shammary, A A Al-Shimemeri, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
March 1, 1984
[Interatrial septal aneurysm. Echocardiographic diagnosis]
M Canny, G Drobinski, D Thomas, et al.
Investigational New Drugs
|
March 30, 2013
A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumors
E Raymond, J Alexandre, S Faivre, et al.
European Journal of Neurology
|
January 30, 2004
A clinical and genetic study of 56 Saudi Wilson disease patients: identification of Saudi-specific mutations
M Al Jumah, R Majumdar, S Al Rajeh, et al.
ESMO Open
|
June 2, 2022
Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis
G Nader-Marta, D Martins-Branco, E Agostinetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1994
Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis
E Tomiak, M J Piccart, J Kerger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2006
Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome?
D Strumberg, A Awada, H Hirte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1995
An EORTC pilot study of filgrastim (recombinant human granulocyte colony stimulating factor) as support to a high dose-intensive epiadriamycin-cyclophosphamide regimen in chemotherapy-naive patients with locally advanced or metastatic breast cancer
M J Piccart, P Bruning, J Wildiers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2009
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
M Schmidt, M E Scheulen, C Dittrich, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 210) with videos related to
Sort By:
Page
of 21
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 13, 2012
Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy
A Awada, L Dirix, L Manso Sanchez, et al.
Saudi Medical Journal
|
September 5, 2001
Complications of carbon monoxide poisoning
M S Al-Moamary, A S Al-Shammary, A A Al-Shimemeri, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
March 1, 1984
[Interatrial septal aneurysm. Echocardiographic diagnosis]
M Canny, G Drobinski, D Thomas, et al.
Investigational New Drugs
|
March 30, 2013
A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumors
E Raymond, J Alexandre, S Faivre, et al.
European Journal of Neurology
|
January 30, 2004
A clinical and genetic study of 56 Saudi Wilson disease patients: identification of Saudi-specific mutations
M Al Jumah, R Majumdar, S Al Rajeh, et al.
ESMO Open
|
June 2, 2022
Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis
G Nader-Marta, D Martins-Branco, E Agostinetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1994
Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis
E Tomiak, M J Piccart, J Kerger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2006
Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome?
D Strumberg, A Awada, H Hirte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1995
An EORTC pilot study of filgrastim (recombinant human granulocyte colony stimulating factor) as support to a high dose-intensive epiadriamycin-cyclophosphamide regimen in chemotherapy-naive patients with locally advanced or metastatic breast cancer
M J Piccart, P Bruning, J Wildiers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2009
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
M Schmidt, M E Scheulen, C Dittrich, et al.
Page
of 21